Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 21:46 | 2026-04-01 | ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $23.88 | 10,000 | $238,801 | 39,744 | -20.1% |
| 2026-03-05 00:16 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.65 | 10,000 | $256,518 | 49,744 | -16.7% |
| 2026-03-05 00:17 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Leonard Keith R | Director | Pharmaceutical Preparations | OPT+S | $25.39 | 39,272 | $997,195 | 22,123 | -64.0% |
| 2026-03-04 04:41 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.18 | 6,287 | $158,320 | 121,150 | -4.9% |
| 2026-03-04 04:42 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Vairavan Latha | Officer; SVP Chief Financial Officer | Pharmaceutical Preparations | SALE | $25.18 | 2,853 | $71,844 | 87,754 | -3.1% |
| 2026-03-04 04:42 | 2026-02-27 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $26.03 | 12,058 | $313,877 | 136,932 | -8.1% |
| 2026-03-04 04:42 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.18 | 37,349 | $940,526 | 785,957 | -4.5% |
| 2026-03-04 04:43 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.18 | 3,687 | $92,846 | 175,178 | -2.1% |
| 2026-02-05 04:35 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.28 | 40,638 | $1,027,292 | 110,003 | -27.0% |
| 2026-02-05 03:25 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.50 | 19,833 | $505,710 | 721,306 | -2.7% |
| 2026-02-05 03:24 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Vairavan Latha | Officer; SVP Chief Financial Officer | Pharmaceutical Preparations | SALE | $25.50 | 1,320 | $33,658 | 63,607 | -2.0% |
| 2026-02-05 03:23 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.05 | 10,000 | $250,483 | 59,744 | -14.3% |
| 2026-02-05 03:21 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.50 | 2,052 | $52,323 | 148,865 | -1.4% |
| 2026-02-05 03:30 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.72 | 13,469 | $346,455 | 80,651 | -14.3% |
| 2026-01-08 01:46 | 2026-01-05 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $28.98 | 2,490 | $72,166 | 94,120 | -2.6% |
| 2026-01-07 01:31 | 2026-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $28.96 | 10,000 | $289,606 | 69,744 | -12.5% |
| 2026-01-03 02:12 | 2025-12-31 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $29.20 | 1,697 | $49,560 | 96,610 | -1.7% |
| 2025-12-18 01:53 | 2025-12-15 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $28.94 | 11,500 | $332,851 | 98,307 | -10.5% |
| 2025-12-04 01:23 | 2025-12-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $30.21 | 10,000 | $302,133 | 79,744 | -11.1% |
| 2025-12-04 01:24 | 2025-12-01 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $30.23 | 1,657 | $50,091 | 150,641 | -1.1% |
| 2025-11-26 02:27 | 2025-11-24 | ARQT | Arcutis Biotherapeutics Inc. | LIN SUE-JEAN | Director | Pharmaceutical Preparations | OPT+S | $30.78 | 25,272 | $777,956 | 26,735 | -48.6% |
| 2025-11-25 02:45 | 2025-11-21 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $30.35 | 50,000 | $1,517,405 | 740,537 | -6.3% |
| 2025-11-22 02:34 | 2025-11-19 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $28.29 | 2,550 | $72,135 | 151,476 | -1.7% |
| 2025-11-22 02:21 | 2025-11-20 | ARQT | Arcutis Biotherapeutics Inc. | Gilbert Halley E | Director | Pharmaceutical Preparations | OPT+S | $27.55 | 16,532 | $455,442 | 22,123 | -42.8% |
| 2025-11-18 03:56 | 2025-11-13 | ARQT | Arcutis Biotherapeutics Inc. | Krishnamohan Neha | Director | Pharmaceutical Preparations | OPT+S | $23.20 | 40,504 | $939,494 | 22,123 | -64.7% |
| 2025-11-11 01:42 | 2025-11-06 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.16 | 29,131 | $732,927 | 150,193 | -16.2% |
| 2025-11-11 01:41 | 2025-11-06 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $24.18 | 17,250 | $417,145 | 98,325 | -14.9% |
| 2025-11-06 02:24 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Vairavan Latha | Officer; SVP Chief Financial Officer | Pharmaceutical Preparations | SALE | $24.72 | 88 | $2,175 | 64,927 | -0.1% |
| 2025-11-06 02:23 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $24.72 | 11,547 | $285,399 | 794,893 | -1.4% |
| 2025-11-06 02:24 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.27 | 10,000 | $252,669 | 89,744 | -10.0% |
| 2025-11-06 02:23 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $24.72 | 7,208 | $178,156 | 154,026 | -4.5% |
| 2025-11-06 02:57 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $24.12 | 6,486 | $156,449 | 98,325 | -6.2% |
| 2025-10-31 02:02 | 2025-10-28 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.03 | 40,000 | $1,001,032 | 806,440 | -4.7% |
| 2025-10-06 22:15 | 2025-10-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $20.04 | 4,504 | $90,263 | 179,324 | -2.5% |
| 2025-10-04 00:02 | 2025-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $19.66 | 45,000 | $884,651 | 846,440 | -5.0% |
| 2025-10-04 00:01 | 2025-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $18.92 | 10,000 | $189,227 | 99,744 | -9.1% |
| 2025-09-11 01:21 | 2025-09-08 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.54 | 10,129 | $177,628 | 891,440 | -1.1% |
| 2025-09-09 00:14 | 2025-09-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $16.16 | 36,130 | $583,716 | 161,234 | -18.3% |
| 2025-09-05 01:41 | 2025-09-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $15.64 | 10,000 | $156,383 | 100,206 | -9.1% |
| 2025-08-22 04:32 | 2025-08-19 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.82 | 4,188 | $66,250 | 104,811 | -3.8% |
| 2025-08-13 00:04 | 2025-08-08 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.03 | 3,847 | $53,988 | 108,999 | -3.4% |
| 2025-08-06 01:29 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.33 | 11,547 | $165,429 | 901,569 | -1.3% |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Vairavan Latha | Officer; SVP Chief Financial Officer | Pharmaceutical Preparations | SALE | $14.33 | 89 | $1,275 | 65,015 | -0.1% |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.33 | 6,330 | $90,687 | 197,364 | -3.1% |
| 2025-08-06 01:28 | 2025-08-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $14.30 | 10,000 | $142,982 | 100,206 | -9.1% |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.33 | 2,622 | $37,564 | 112,846 | -2.3% |
| 2025-07-14 23:02 | 2025-07-10 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $15.05 | 28,750 | $432,699 | 115,468 | -19.9% |
| 2025-07-02 23:25 | 2025-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.84 | 9,208 | $127,430 | 100,206 | -8.4% |
| 2025-06-20 23:32 | 2025-06-18 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.37 | 10,139 | $135,574 | 109,414 | -8.5% |
| 2025-06-18 00:45 | 2025-06-13 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $13.08 | 2,646 | $34,610 | 27,448 | +10.7% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.